Kalbe Farma Konsolidasikan Entitas ke Bisnis Biofarma
PT Kalbe Farma Tbk (KLBF) berencana mengkonsolidasikan entitas usaha, yakni Innogene Kalbiotech Pte Ltd (IGK) dan PT Kalbio Global Medika (KGM) dengan PT Kalbe Genexine Biologics (KGB).
BISNIS-27 | ||
511.883 | ||
-0.0370 | -0.0001% |
COMPOSITE | ||
6,731.079 | ||
-3.7530 | -0.0006% |
DBX | ||
1,577.798 | ||
-18.2040 | -0.0114% |
I-GRADE | ||
209.600 | ||
-0.2600 | -0.0012% |
IDX30 | ||
416.107 | ||
-1.0280 | -0.0025% |
IDX80 | ||
118.764 | ||
-0.4600 | -0.0039% |
IDXBUMN20 | ||
346.229 | ||
0.6090 | 0.0018% |
AUDRP | ||
10,925.100 | ||
15.7000 | 0.1439% |
EURRP | ||
17,536.900 | ||
12.3000 | 0.0702% |
JPYRP | ||
102.250 | ||
0.1910 | 0.1871% |
RP | ||
16,405.000 | ||
-5.0000 | -0.0305% |
SINRP | ||
12,086.700 | ||
13.4000 | 0.1110% |
PT Kalbe Farma Tbk (KLBF) berencana mengkonsolidasikan entitas usaha, yakni Innogene Kalbiotech Pte Ltd (IGK) dan PT Kalbio Global Medika (KGM) dengan PT Kalbe Genexine Biologics (KGB).